En esta página
ARQT Arcutis Biotherapeutics, Inc. - Common stock
NASDAQ · Biotechnology · Ver en SEC EDGAR ↗ cerrar Oct 2, 2026 10-K/10-Q Ago 5, 2026
$25,16
· % del rango de 52 semanas
· por encima del mínimo
· a alto
$19,30mínimo 52 semanas
$31,77máximo 52 semanas
Capitalización Bursátil (MRQ)
$3.16B
P/E (TTM)
114.4
BPA (TTM)
$0.22
Ingresos (TTM)
$464M
tus insignias
Rango 52S
$19–$32
Calificación del Analista
BUY
Precio Objetivo
$37
P/E
114.4
ROE
15.9%
Margen de Beneficio Neto
6.1%
Tu barra de insignias está vacía — fija una métrica en cualquier lugar de esta página.
ARQT Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$25.16
Capitalización Bursátil (MRQ)
$3.16B
P/E (TTM)
114.4
BPA (TTM)
$0.22
Ingresos (TTM)
$464M
ROE (TTM)
15.9%
Deuda/Capital (MRQ)
0.5
Rango 52S
$19–$32
ARQT Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
rango
barras
La granularidad de las barras se adapta al período seleccionado; pase el ratón sobre el gráfico para ver la apertura/máximo/mínimo/cierre de una barra.
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
Ingresos$376M2020-12-31 → 2025-12-31
BPA$-0.132019-12-31 → 2025-12-31
Flujo de caja libre$-6M2020-12-31 → 2025-12-31
Margen neto6.1%2023-12-31 → 2025-12-31
Valoración y ratios
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
| Métrica | Tendencia a 5 años | ARQT | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| P/E (TTM) | 114.4promedio 5A ≈-48.8 | ≈-48.8 | 27.9 | Sobrevalorado | |
| P/S (TTM) | 6.8promedio 5A ≈7.7 | ≈7.7 | 11.9 | Infravalorado | |
| P/C (MRQ) | 14.3promedio 5A ≈10.9 | ≈10.9 | 4.9 | Sobrevalorado | |
| EV / EBITDA | -259.2promedio 5A ≈-104.4 | ≈-104.4 | · | · | |
| Precio / FCF (TTM) | 80.7promedio 5A ≈-194.5 | ≈-194.5 | · | · | |
| Precio / Flujo de Caja (TTM) | 80.4promedio 5A ≈-217.5 | ≈-217.5 | · | · | |
| EV / Revenue (EV / Ingresos) | 8.4promedio 5A ≈8.5 | ≈8.5 | · | · | |
| EV / FCF | -502.2promedio 5A ≈-198.2 | ≈-198.2 | · | · | |
| Precio / Valor Contable Tangible (MRQ) | 15.3promedio 5A ≈8.7 | ≈8.7 | · | · |
La mediana de empresas comparables se calcula sobre una base estandarizada por métrica y puede no coincidir siempre con la base TTM/MRQ que se muestra para esta acción.
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
| Métrica | Tendencia a 5 años | ARQT | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Margen Operativo (TTM) | 7.4%promedio 5A ≈-157.7% | ≈-157.7% | 12.5% | En línea | |
| EBITDA Margin (Margen EBITDA) | -3.2%promedio 5A ≈-157.7% | ≈-157.7% | 12.5% | En línea | |
| Margen de Beneficio Neto (TTM) | 6.1%promedio 5A ≈-171.8% | ≈-171.8% | 10.2% | En línea | |
| ROA (TTM) | 6.8%promedio 5A ≈-37.0% | ≈-37.0% | -13.8% | De primer nivel | |
| ROE (TTM) | 15.9%promedio 5A ≈-162.1% | ≈-162.1% | -10.7% | En línea |
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
| Métrica | Tendencia a 5 años | ARQT | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Deuda / Patrimonio (MRQ) | 0.5promedio 5A ≈1.2 | ≈1.2 | · | · | |
| Ratio corriente (MRQ) | 2.9promedio 5A ≈4.8 | ≈4.8 | 4.6 | Baja liquidez | |
| Quick Ratio (Ratio Rápido) | 1.5promedio 5A ≈1.9 | ≈1.9 | 4.1 | Baja liquidez | |
| Deuda a Largo Plazo / Patrimonio (MRQ) | 0.5promedio 5A ≈1.2 | ≈1.2 | · | · |
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
| Métrica | Tendencia a 5 años | ARQT | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Revenue YoY (Ingresos interanuales) | 91.3%promedio 5A ≈612.7% | ≈612.7% | · | · | |
| Revenue CAGR 3Y (Ingresos CAGR 3A) | 367.3% | · | · | · |
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
| Métrica | Tendencia a 5 años | ARQT | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Asset Turnover (Rotación de Activos) | 1.0promedio 5A ≈0.6 | ≈0.6 | 0.4 | De primer nivel | |
| Inventory Turnover (Rotación de Inventario) | 2.0promedio 5A ≈1.3 | ≈1.3 | · | · | |
| Receivables Turnover (Rotación de Cuentas por Cobrar) | 3.4promedio 5A ≈3.6 | ≈3.6 | 8.4 | Débil | |
| Revenue / Employee (Ingresos / Empleado) | ≈$1.1M | · | · | · |
valor · ≈ promedio 5A · mediana sectorial · veredicto relativo a la mediana
Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
Sorpresa Media
56.7%
Próximo informe
Oct 26, 2026
| Período | Informe | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|---|
| 30 de junio de 2026 | Ago 4, 2026 | $0.11 | $0.04 | 150.6% |
| 31 de marzo de 2026 | $-0.09 | $-0.08 | -7.4% | |
| 31 de diciembre de 2025 | $0.13 | $0.12 | 12.4% | |
| 30 de septiembre de 2025 | $0.06 | $-0.10 | 158.9% | |
| 30 de junio de 2025 | $-0.13 | $-0.16 | 19.4% | |
| 31 de marzo de 2025 | $-0.20 | $-0.21 | 6.6% |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | $376M | $197M | $60M | $4M | $0 | $0 | |
| Cost of Revenue | $37M | $19M | $5M | $754.0K | $0 | · | |
| R&D Expense | $77M | $76M | $111M | $182M | $146M | $115M | |
| SG&A Expense | $275M | $229M | $185M | $122M | $61M | $21M | |
| Operating Expenses | $388M | $325M | $301M | $305M | $207M | $137M | |
| Operating Income | $-12M | $-128M | $-241M | $-302M | $-207M | $-137M | |
| Interest Expense | · | · | $30M | $16M | $0 | $0 | |
| Other Non-op | $443.0K | $47.0K | $-731.0K | $6M | $173.0K | $967.0K | |
| Income Tax | $1M | $647.0K | $3M | $0 | $0 | $0 | |
| Net Income | $-16M | $-140M | $-262M | $-311M | $-206M | $-136M | |
| EPS (Basic) | $-0.13 | $-1.16 | $-3.78 | $-5.66 | $-4.18 | $-3.80 | |
| EPS (Diluted) | $-0.13 | $-1.16 | $-3.78 | $-5.66 | $-4.18 | $-3.80 | |
| Shares (Basic) | 127,234,000 | 120,958,000 | 69,305,000 | 55,032,265 | 49,405,575 | 35,668,152 | |
| Shares (Diluted) | 127,234,000 | 120,958,000 | 69,305,000 | 55,032,265 | 49,405,575 | 35,668,152 | |
| EBITDA | $-12M | $-128M | $-241M | · | · | $-137M |
Balance general
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $43M | $71M | $88M | $54M | $96M | $65M | |
| Receivables | $146M | $73M | $26M | $8M | $0 | · | |
| Inventory | $23M | $15M | $13M | $8M | $0 | · | |
| Prepaid Expense | $21M | $20M | $19M | $11M | $14M | $7M | |
| Current Assets | $411M | $336M | $330M | $437M | $403M | $293M | |
| PP&E (Net) | $1M | $1M | $2M | $2M | $2M | $2M | |
| PP&E (Gross) | $4M | $4M | $3M | $3M | $3M | $2M | |
| Accum. Depreciation | $3M | $3M | $2M | $1M | $532.0K | $78.0K | |
| Intangibles | $15M | $9M | $6M | $7M | $0 | · | |
| Other Non-current Assets | $1M | $596.0K | $596.0K | $78.0K | $78.0K | $78.0K | |
| Total Assets | $433M | $349M | $341M | $449M | $408M | $298M | |
| Accounts Payable | $13M | $14M | $12M | $9M | $7M | $7M | |
| Accrued Liabilities | $116M | $67M | $34M | $28M | $26M | $15M | |
| Current Liabilities | $130M | $81M | $47M | $38M | $33M | $23M | |
| Capital Leases | $5M | $3M | $3M | $4M | $5M | $5M | |
| Other Non-current Liabilities | $431.0K | $570.0K | $849.0K | $0 | $25.0K | $82.0K | |
| Total Liabilities | $243M | $191M | $253M | $240M | $110M | $28M | |
| Long-term Debt | $109M | $107M | $202M | $198M | $72M | $0 | |
| Total Debt | $109M | $107M | $202M | · | · | · | |
| Common Stock | $12.0K | $12.0K | $9.0K | $6.0K | $5.0K | $4.0K | |
| Paid-in Capital | $1.33B | $1.28B | $1.07B | $930M | $706M | $473M | |
| Retained Earnings | $-1.14B | $-1.12B | $-982M | $-720M | $-408M | $-202M | |
| AOCI | $-44.0K | $-7.0K | $4.0K | $-1M | $-255.0K | $-2.0K | |
| Stockholders' Equity | $189M | $158M | $89M | $210M | $298M | $271M | |
| Liabilities + Equity | $433M | $349M | $341M | $449M | $408M | $298M | |
| Shares Outstanding | 123,333,000 | 117,848,033 | 96,787,343 | 61,037,403 | 50,255,614 | 43,338,438 |
Flujo de Efectivo
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Stock-based Comp | $40M | $42M | $39M | $33M | $24M | $8M | |
| Deferred Tax | $54.0K | $-152.0K | $0 | $0 | $0 | · | |
| Amort. of Intangibles | $5M | $2M | $750.0K | $312.0K | $0 | $0 | |
| Operating Cash Flow | $-6M | $-112M | $-247M | $-258M | $-175M | $-113M | |
| CapEx | $686.0K | $143.0K | $428.0K | $333.0K | $995.0K | $321.0K | |
| Investing Cash Flow | $-30M | $29M | $180M | $-87M | $-76M | $-182M | |
| Debt Issued | · | $0 | $0 | $125M | $74M | $0 | |
| Net Debt Issued | $0 | $-100M | $0 | · | · | · | |
| Stock Issued | $0 | $162M | $0 | $162M | $207M | $128M | |
| Net Stock Activity | $0 | $162M | $0 | · | · | $128M | |
| Financing Cash Flow | $7M | $66M | $101M | $302M | $282M | $298M | |
| Net Change in Cash | $-29M | $-17M | $34M | $-43M | $31M | $3M | |
| Taxes Paid | $0 | $0 | $0 | · | · | · | |
| Free Cash Flow | $-6M | $-112M | $-247M | · | · | $-113M |
Rentabilidad
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Operating Margin | -3.2% | -65.3% | -404.5% | · | · | · | |
| Net Margin | -4.3% | -71.2% | -439.8% | · | · | · | |
| EBITDA Margin | -3.2% | -65.3% | -404.5% | · | · | · | |
| ROA | -4.1% | -40.6% | -66.3% | · | · | -67.0% | |
| ROE | -9.8% | -89.1% | -387.2% | · | · | -61.2% |
Liquidez y Solvencia
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 3.2 | 4.1 | 7.1 | · | · | 13.0 | |
| Quick Ratio | 1.5 | 1.8 | 2.4 | · | · | 2.9 | |
| Debt / Equity | 0.6 | 0.7 | 2.3 | · | · | · | |
| LT Debt / Equity | 0.6 | 0.7 | 2.3 | · | · | · | |
| Interest Coverage | · | · | -8.1 | · | · | · |
Eficiencia
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | 1.0 | 0.6 | 0.2 | · | · | · | |
| Inventory Turnover | 2.0 | 1.4 | 0.5 | · | · | · | |
| Receivables Turnover | 3.4 | 4.0 | 3.5 | · | · | · |
Por Acción
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.54 | $1.34 | $0.92 | · | · | $6.24 | |
| Revenue / Share | $2.96 | $1.62 | $0.86 | · | · | · | |
| Cash Flow / Share | $-0.04 | $-0.93 | $-3.56 | · | · | · | |
| Cash / Share | $0.35 | $0.61 | $0.91 | · | · | $1.50 | |
| EPS (TTM) | $-0.13 | $-1.16 | $-3.78 | $-5.66 | $-4.18 | $-3.80 |
Tasas de Crecimiento
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue YoY | 91.3% | 229.7% | 1517.1% | · | · | · | |
| Revenue CAGR 3Y | 367.3% | · | · | · | · | · |
Valoración (TTM)
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue TTM | $376M | $197M | $60M | $4M | $0 | $0 | |
| Net Income TTM | $-16M | $-140M | $-262M | $-311M | $-206M | $-136M | |
| Market Cap | $3.58B | $1.64B | $313M | · | · | $1.22B | |
| Enterprise Value | $3.65B | $1.68B | $426M | · | · | · | |
| P/E | -223.4 | -12.0 | -0.9 | -2.6 | -5.0 | -7.4 | |
| P/S | 9.5 | 8.4 | 5.2 | · | · | · | |
| P/B | 18.9 | 10.4 | 3.5 | · | · | 4.5 | |
| P / Tangible Book | 20.5 | 11.1 | 3.8 | 4.5 | 3.5 | 4.5 | |
| P / Cash Flow | -636.7 | -14.6 | -1.3 | · | · | -10.8 | |
| P / FCF | -567.5 | -14.6 | -1.3 | · | · | -10.8 | |
| EV / EBITDA | -298.3 | -13.1 | -1.8 | · | · | · | |
| EV / FCF | -578.0 | -14.9 | -1.7 | · | · | · | |
| EV / Revenue | 9.7 | 8.5 | 7.1 | · | · | · | |
| Earnings Yield | -0.45% | -8.3% | -117.0% | -38.2% | -20.2% | -13.5% |
Estado de resultados
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $130M | $105M | $130M | $99M | $82M | $66M | $71M | $45M | $31M | $50M | $14M | $38M | $5M | $3M | $3M | $725.0K | |
| Cost of Revenue | $11M | $10M | $12M | $9M | $7M | $9M | $7M | $6M | $3M | $3M | $2M | $1M | $776.0K | $783.0K | · | · | |
| R&D Expense | $20M | $31M | $20M | $20M | $19M | $18M | $14M | $20M | $19M | $23M | $24M | $26M | $25M | $35M | $34M | $70M | |
| SG&A Expense | $82M | $74M | $79M | $62M | $69M | $64M | $58M | $59M | $58M | $55M | $49M | $48M | $46M | $43M | $37M | $35M | |
| Operating Expenses | $113M | $114M | $111M | $91M | $96M | $90M | $79M | $84M | $81M | $81M | $75M | $75M | $72M | $79M | $71M | $105M | |
| Operating Income | $16M | $-9M | $18M | $9M | $-15M | $-25M | $-8M | $-39M | $-50M | $-32M | $-61M | $-37M | $-67M | $-76M | $-68M | $-105M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $7M | · | $8M | $7M | $7M | · | $5M | |
| Interest Income | $2M | · | · | · | $2M | · | · | · | · | · | · | · | · | · | · | · | |
| Other Non-op | $-157.0K | $-20.0K | $-6M | $2M | $20.0K | $193.0K | $-13M | $4M | $5M | $4M | $-10M | $3M | $3M | $3M | $3M | $2M | |
| Income Tax | $136.0K | $93.0K | $470.0K | $80.0K | $342.0K | $279.0K | $323.0K | $0 | $0 | $324.0K | $90.0K | $3M | $0 | $0 | $0 | $0 | |
| Net Income | $15M | $-11M | $17M | $7M | $-16M | $-25M | $-11M | $-42M | $-52M | $-35M | $-66M | $-45M | $-71M | $-80M | $-72M | $-108M | |
| EPS (Basic) | $0.11 | $-0.09 | $0.14 | $0.06 | $-0.13 | $-0.20 | $-0.09 | $-0.33 | $-0.42 | $-0.32 | $-0.58 | $-0.73 | $-1.16 | $-1.31 | $-1.19 | $-1.89 | |
| EPS (Diluted) | $0.11 | $-0.09 | $0.14 | $0.06 | $-0.13 | $-0.20 | $-0.09 | $-0.33 | $-0.42 | $-0.32 | $-0.58 | $-0.73 | $-1.16 | $-1.31 | $-1.19 | $-1.89 | |
| Shares (Basic) | 130,522,000 | 129,365 | · | 127,623,000 | 126,997,000 | 126,037 | · | 124,302,000 | 123,481,000 | 111,048,525 | · | 61,727,278 | 61,430,620 | 61,169,089 | · | 57,091,743 | |
| Shares (Diluted) | 135,898,000 | 129,365 | · | 132,885,000 | 126,997,000 | 126,037 | · | 124,302,000 | 123,481,000 | 111,048,525 | · | 61,727,278 | 61,430,620 | 61,169,089 | · | 57,091,743 | |
| EBITDA | $16M | $-9M | · | $9M | $-15M | $-25M | · | $-39M | $-50M | · | · | $-37M | · | · | · | $-105M |
Balance general
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $34M | $35M | $43M | $47M | $73M | $53M | $71M | $135M | $84M | $190M | · | $107M | $105M | $81M | · | $82M | |
| Receivables | $155M | $144M | $146M | $115M | $107M | $85M | $73M | $60M | $43M | $37M | · | $19M | $17M | $13M | · | $2M | |
| Inventory | $39M | $37M | $23M | $22M | $16M | $17M | $15M | $14M | $14M | $13M | · | $14M | $10M | $9M | · | $4M | |
| Prepaid Expense | $35M | $32M | $21M | $20M | $19M | $23M | $20M | $18M | $14M | $13M | · | $20M | $12M | $13M | · | $12M | |
| Current Assets | $468M | $438M | $411M | $349M | $333M | $324M | $336M | $424M | $435M | $468M | · | $282M | $309M | $368M | · | $497M | |
| PP&E (Net) | $872.0K | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | · | $2M | $2M | $2M | · | $2M | |
| PP&E (Gross) | · | · | $4M | · | · | · | $4M | · | · | · | · | $3M | $3M | $3M | · | $3M | |
| Accum. Depreciation | · | · | $3M | · | · | · | $3M | · | · | · | · | $2M | $2M | $1M | · | $993.0K | |
| Intangibles | $14M | $14M | $15M | $15M | $16M | $16M | $9M | $10M | $6M | $6M | · | $7M | $7M | $7M | · | $7M | |
| Other Non-current Assets | $2M | $2M | $1M | $596.0K | $596.0K | $596.0K | $596.0K | $596.0K | $595.0K | $596.0K | · | $596.0K | $596.0K | $78.0K | · | $78.0K | |
| Total Assets | $489M | $460M | $433M | $371M | $352M | $344M | $349M | $437M | $445M | $479M | · | $293M | $321M | $379M | · | $509M | |
| Accounts Payable | $7M | $18M | $13M | $6M | $15M | $25M | $14M | $19M | $8M | $13M | · | $13M | $17M | $12M | · | $9M | |
| Accrued Liabilities | $147M | $137M | $116M | $93M | $88M | $66M | $67M | $53M | $43M | $34M | · | $28M | $19M | $24M | · | $28M | |
| Current Liabilities | $160M | $163M | $130M | $100M | $104M | $91M | $81M | $172M | $51M | $47M | · | $42M | $37M | $37M | · | $37M | |
| Capital Leases | $5M | $5M | $5M | $5M | $2M | $2M | $3M | $3M | $3M | $3M | · | $4M | $4M | $4M | · | $4M | |
| Other Non-current Liabilities | $431.0K | $431.0K | $431.0K | $360.0K | $360.0K | $360.0K | $570.0K | $420.0K | $194.0K | $306.0K | · | · | · | · | · | $0 | |
| Total Liabilities | $268M | $270M | $243M | $213M | $213M | $201M | $191M | $281M | $258M | $254M | · | $246M | $240M | $240M | · | $238M | |
| Long-term Debt | $109M | $109M | $109M | $108M | $108M | $108M | $107M | $205M | $204M | $203M | · | $201M | $200M | $199M | · | $197M | |
| Total Debt | $109M | $109M | · | $108M | $108M | $108M | · | $205M | $204M | · | · | $201M | · | · | · | $197M | |
| Common Stock | $12.0K | $12.0K | $12.0K | $12.0K | $12.0K | $12.0K | $12.0K | $12.0K | $12.0K | $12.0K | · | $6.0K | $6.0K | $6.0K | · | $6.0K | |
| Paid-in Capital | $1.36B | $1.34B | $1.33B | $1.31B | $1.30B | $1.29B | $1.28B | $1.27B | $1.26B | $1.24B | · | $963M | $952M | $940M | · | $920M | |
| Retained Earnings | $-1.13B | $-1.15B | $-1.14B | $-1.16B | $-1.16B | $-1.15B | $-1.12B | $-1.11B | $-1.07B | $-1.02B | · | $-916M | $-871M | $-800M | · | $-648M | |
| AOCI | $-656.0K | $-514.0K | $-44.0K | $-62.0K | $-35.0K | $-140.0K | $-7.0K | $533.0K | $-294.0K | $-133.0K | · | $-184.0K | $-292.0K | $-414.0K | · | $-2M | |
| Stockholders' Equity | $221M | $190M | $189M | $158M | $139M | $143M | $158M | $157M | $186M | $225M | $89M | $47M | $81M | $140M | $210M | $271M | |
| Liabilities + Equity | $489M | $460M | $433M | $371M | $352M | $344M | $349M | $437M | $445M | $479M | · | $293M | $321M | $379M | · | $509M | |
| Shares Outstanding | 125,591,000 | 125,042,000 | 123,332,672 | 120,288,146 | 119,797,738 | 119,137,785 | 117,848,033 | 116,998,829 | 116,480,267 | 115,505,437 | · | 61,858,044 | 61,630,018 | 61,357,932 | · | 60,908,641 |
Flujo de Efectivo
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $13M | $11M | $10M | $10M | $10M | $10M | $9M | $10M | $13M | $10M | $9M | $10M | $11M | $9M | $9M | $9M | |
| Amort. of Intangibles | $563.0K | $562.0K | $563.0K | $562.0K | $563.0K | $3M | $313.0K | $1M | $200.0K | $188.0K | $-188M | $188M | $200.0K | $188.0K | $187.0K | $125.0K | |
| Operating Cash Flow | $13M | $2M | $26M | $-2M | $324.0K | $-30M | $-748.0K | $-35M | $-45M | $-32M | $-56M | $-44M | $-66M | $-80M | $-71M | $-68M | |
| CapEx | $158.0K | $0 | $0 | $0 | $78.0K | $608.0K | $0 | $143.0K | $0 | $0 | $6.0K | $64.0K | $276.0K | $82.0K | $123.0K | $6.0K | |
| Investing Cash Flow | $-15M | $-11M | $-34M | $-25M | $17M | $12M | $35M | $85M | $-62M | $-29M | $-62M | $46M | $89M | $108M | $42M | $-197M | |
| Debt Issued | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | · | |
| Stock Issued | · | · | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $162M | $0 | $0 | $0 | $0 | $0 | $162M | |
| Net Stock Activity | · | · | · | · | · | $0 | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $2M | $1M | $4M | $1M | $1M | $395.0K | $-97M | $394.0K | $1M | $162M | $99M | $867.0K | $1M | $100.0K | $962.0K | $285M | |
| Net Change in Cash | $-641.0K | $-8M | $-4M | $-26M | $19M | $-18M | $-64M | $51M | $-106M | $101M | $-19M | $2M | $24M | $27M | $-28M | $20M | |
| Free Cash Flow | · | $2M | · | · | · | $-31M | · | · | · | · | · | · | · | · | · | · |
Rentabilidad
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 12.7% | -8.6% | · | 8.6% | -17.9% | -37.2% | · | -87.3% | -162.3% | · | · | -96.8% | · | · | · | -14448.0% | |
| Net Margin | 11.6% | -10.7% | · | 7.5% | -19.5% | -38.1% | · | -92.8% | -169.6% | · | · | -117.5% | · | · | · | -14856.4% | |
| EBITDA Margin | 12.7% | -8.6% | · | 8.6% | -17.9% | -37.2% | · | -87.3% | -162.3% | · | · | -96.8% | · | · | · | -14448.0% | |
| ROA | 3.6% | -2.8% | · | 1.8% | -4.0% | -6.1% | · | -11.4% | -13.7% | · | · | -11.2% | · | · | · | -24.0% | |
| ROE | 8.3% | -6.8% | · | 4.7% | -9.8% | -13.6% | · | -40.8% | -39.2% | · | · | -28.2% | · | · | · | -34.0% |
Liquidez y Solvencia
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.9 | 2.7 | · | 3.5 | 3.2 | 3.6 | · | 2.5 | 8.5 | · | · | 6.7 | · | · | · | 13.4 | |
| Quick Ratio | 1.2 | 1.1 | · | 1.6 | 1.7 | 1.5 | · | 1.1 | 2.5 | · | · | 3.0 | · | · | · | 2.3 | |
| Debt / Equity | 0.5 | 0.6 | · | 0.7 | 0.8 | 0.8 | · | 1.3 | 1.1 | · | · | 4.3 | · | · | · | 0.7 | |
| LT Debt / Equity | 0.5 | 0.5 | · | 0.7 | 0.8 | 0.8 | · | 0.7 | 1.1 | · | · | 4.3 | · | · | · | 0.7 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | · | · | -4.9 | · | · | · | -21.4 |
Eficiencia
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.3 | · | 0.2 | 0.2 | 0.2 | · | 0.1 | 0.1 | · | · | 0.1 | · | · | · | 0.0 | |
| Inventory Turnover | 0.4 | 0.4 | · | 0.5 | 0.5 | 0.6 | · | 0.4 | 0.3 | · | · | · | · | · | · | · | |
| Receivables Turnover | 1.0 | 0.9 | · | 1.1 | 1.1 | 1.1 | · | 1.1 | 1.0 | · | · | 3.5 | · | · | · | 0.6 |
Por Acción
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.76 | $1.52 | · | $1.31 | $1.16 | $1.20 | · | $1.34 | $1.60 | · | · | $0.76 | · | · | · | $4.45 | |
| Revenue / Share | $0.96 | $814.73 | · | $0.75 | $0.64 | $0.52 | · | $0.36 | $0.25 | · | · | $0.62 | · | · | · | $0.01 | |
| Cash Flow / Share | · | $17.31 | · | · | · | $-0.24 | · | · | · | · | · | · | · | · | · | · | |
| Cash / Share | $0.27 | $0.28 | · | $0.39 | $0.61 | $0.45 | · | $1.15 | $0.72 | · | · | $1.74 | · | · | · | $1.34 | |
| EPS (TTM) | $0.22 | $-0.02 | · | $-0.36 | $-0.75 | $-1.04 | · | $-1.65 | $-2.05 | $-3.52 | · | $-4.39 | $-5.67 | $-5.78 | · | $-5.91 |
Valoración (TTM)
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $464M | $416M | · | $318M | $263M | $213M | · | $139M | $132M | $96M | · | $49M | $9M | $4M | · | $725.0K | |
| Net Income TTM | $29M | $-2M | · | $-44M | $-93M | $-130M | · | $-196M | $-199M | $-231M | · | $-268M | $-326M | $-320M | · | $-311M | |
| Market Cap | $3.29B | $2.95B | · | $2.27B | $1.68B | $1.86B | · | $1.09B | $1.08B | · | · | $328M | · | · | · | $1.16B | |
| Enterprise Value | $3.37B | $3.02B | · | $2.33B | $1.71B | $1.92B | · | $1.16B | $1.20B | · | · | $422M | · | · | · | $1.28B | |
| P/E | 119.2 | -1178.0 | · | -52.4 | -18.7 | -15.0 | · | -5.6 | -4.5 | -2.8 | · | -1.2 | -1.7 | -1.9 | · | -3.2 | |
| P/S | 7.1 | 7.1 | · | 7.1 | 6.4 | 8.8 | · | 7.8 | 8.2 | · | · | 6.7 | · | · | · | 1605.5 | |
| P/B | 14.9 | 15.5 | · | 14.3 | 12.1 | 13.1 | · | 6.9 | 5.8 | · | · | 7.0 | · | · | · | 4.3 | |
| P / Tangible Book | 15.9 | 16.8 | · | 15.9 | 13.7 | 14.8 | · | 7.4 | 6.0 | 5.2 | · | 8.2 | 8.0 | 5.1 | · | 4.4 | |
| P / Cash Flow | · | 1315.8 | · | · | · | -61.3 | · | · | · | · | · | · | · | · | · | · | |
| EV / Revenue | 7.3 | 7.3 | · | 7.3 | 6.5 | 9.0 | · | 8.3 | 9.1 | · | · | 8.6 | · | · | · | 1764.4 | |
| Earnings Yield | 0.84% | -0.08% | · | -1.9% | -5.3% | -6.7% | · | -17.7% | -22.0% | -35.5% | · | -82.7% | -59.5% | -52.5% | · | -30.9% |
Período más reciente a la izquierda · valores nulos mostrados como ·
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ingresos | $376M | $197M | $60M | $4M | $0 |
| Margen Operativo % | -3.2% | -65.3% | -404.5% | · | · |
| Beneficio neto | $-16M | $-140M | $-262M | $-311M | $-206M |
| EPS Diluido | $-0.13 | $-1.16 | $-3.78 | $-5.66 | $-4.18 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Deuda / Patrimonio | 0.6 | 0.7 | 2.3 | · | · |
| Ratio corriente | 3.2 | 4.1 | 7.1 | · | · |
| Ratio Rápido | 1.5 | 1.8 | 2.4 | · | · |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Flujo de caja libre | $-6M | $-112M | $-247M | · | · |
Propietarios institucionales (13F) 289 declarantes · $3.6B total · A fecha de 30 de septiembre de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
Tenedores
289
Valor en tenencia
$3.6B
Nuevas posiciones
39
Posiciones cerradas
33
Actividad institucional — Q2 2026 vs trimestre anterior
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 39 (-4 vs trimestre anterior) | 33 (-9 vs trimestre anterior) | 93 (-10 vs trimestre anterior) | 101 (+13 vs trimestre anterior) | -1.9M |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| MONTANOVA CAPITAL, LLC | $326 098 140 | 12 437 000 | 8,97% | Acciones |
| BlackRock, Inc. | $276 502 120 | 10 545 466 | 7,61% | Acciones |
| Frazier Life Sciences Management, L.P. | $258 909 678 | 9 874 511 | 7,12% | Acciones |
| Rubric Capital Management LP | $216 880 749 | 8 271 577 | 5,97% | Acciones |
| VANGUARD GROUP INC | $210 654 301 | 7 253 936 | 5,80% | Acciones |
| Polar Capital Holdings Plc | $173 234 098 | 6 606 945 | 4,77% | Acciones |
| STATE STREET CORP | $152 674 865 | 5 822 840 | 4,20% | Acciones |
| VANGUARD CAPITAL MANAGEMENT LLC | $130 805 182 | 4 988 756 | 3,60% | Acciones |
| MORGAN STANLEY | $116 705 607 | 4 451 014 | 3,21% | Acciones |
| JENNISON ASSOCIATES LLC | $110 623 703 | 4 219 058 | 3,04% | Acciones |
| D. E. Shaw & Co., Inc. | $103 558 748 | 3 949 609 | 2,85% | Acciones |
| UBS Group AG | $87 391 654 | 3 333 015 | 2,40% | Acciones |
| BANK OF AMERICA CORP /DE/ | $78 330 441 | 2 987 431 | 2,16% | Acciones |
| GEODE CAPITAL MANAGEMENT, LLC | $78 214 092 | 2 982 446 | 2,15% | Acciones |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $63 688 511 | 2 429 005 | 1,75% | Acciones |
| ORBIMED ADVISORS LLC | $53 541 240 | 2 042 000 | 1,47% | Acciones |
| FRANKLIN RESOURCES INC | $50 630 354 | 1 930 982 | 1,39% | Acciones |
| AMERICAN CENTURY COMPANIES INC | $50 474 363 | 1 925 031 | 1,39% | Acciones |
| GOLDMAN SACHS GROUP INC | $43 744 582 | 1 668 367 | 1,20% | Acciones |
| JANUS HENDERSON GROUP PLC | $43 684 303 | 1 854 566 | 1,20% | Acciones |
| OBERWEIS ASSET MANAGEMENT INC/ | $35 998 513 | 1 372 941 | 0,99% | Acciones |
| GILDER GAGNON HOWE & CO LLC | $34 432 392 | 1 313 211 | 0,95% | Acciones |
| Pivotal bioVenture Partners Investment Advisor LLC | $33 175 720 | 1 265 283 | 0,91% | Acciones |
| BAMCO INC /NY/ | $32 856 806 | 1 253 120 | 0,90% | Acciones |
| CITADEL ADVISORS LLC | $30 415 567 | 1 160 014 | 0,84% | Acciones |
| FEDERATED HERMES, INC. | $29 487 772 | 1 124 629 | 0,81% | Acciones |
| Perpetual Ltd | $29 095 206 | 1 109 657 | 0,80% | Acciones |
| Aberdeen Group plc | $28 800 336 | 1 098 411 | 0,79% | Acciones |
| Jones Hill Capital LP | $28 571 960 | 1 089 701 | 0,79% | Acciones |
| NORTHERN TRUST CORP | $27 755 837 | 1 058 575 | 0,76% | Acciones |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $27 555 489 | 1 050 934 | 0,76% | Acciones |
| Ensign Peak Advisors, Inc | $25 552 281 | 974 534 | 0,70% | Acciones |
| Candriam S.C.A. | $24 880 817 | 949 839 | 0,68% | Acciones |
| Driehaus Capital Management LLC | $23 032 330 | 878 426 | 0,63% | Acciones |
| Nuveen, LLC | $21 874 324 | 834 261 | 0,60% | Acciones |
| VANGUARD FIDUCIARY TRUST CO | $21 372 918 | 815 138 | 0,59% | Acciones |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $21 284 137 | 811 752 | 0,59% | Acciones |
| TWO SIGMA INVESTMENTS, LP | $17 406 855 | 663 877 | 0,48% | Acciones |
| FISHMAN JAY A LTD/MI | $15 601 031 | 595 005 | 0,43% | Acciones |
| MILLENNIUM MANAGEMENT LLC | $14 789 968 | 564 072 | 0,41% | Acciones |
| BNP PARIBAS FINANCIAL MARKETS | $14 349 629 | 547 278 | 0,39% | Acciones |
| Squarepoint Ops LLC | $14 099 726 | 537 747 | 0,39% | Acciones |
| CAPITOLIS LIQUID GLOBAL MARKETS LLC | $13 110 000 | 500 000 | 0,36% | Acciones |
| Nearwater Capital Markets, Ltd | $12 761 274 | 486 700 | 0,35% | Acciones |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $12 218 520 | 466 000 | 0,34% | Acciones |
| MARSHALL WACE, LLP | $11 716 827 | 446 866 | 0,32% | Acciones |
| Privium Fund Management B.V. | $10 471 403 | 399 367 | 0,29% | Acciones |
| NORGES BANK | $10 286 106 | 392 300 | 0,28% | Acciones |
| DEUTSCHE BANK AG\ | $10 033 923 | 382 682 | 0,28% | Acciones |
| Patient Square Capital LP | $9 701 400 | 370 000 | 0,27% | Acciones |
Activistas y propietarios del %+ 5 3 tenencias
Inversores que presentaron el Anexo 13D de la SEC — propiedad beneficiosa superior al % 5 con la intención de influir en el emisor (participaciones activistas, campañas de la junta directiva, M&A). Cada fila muestra el estado conocido más reciente de la posición de ese declarante.
| Declarante | Presentado | Participación | Estado | Propósito | Presentación |
|---|---|---|---|---|---|
| Frazier Life Sciences VIII, L.P., FHM LIFE SCIENCES VIII, L.P., FHM LIFE SCIENCES VIII, L.L.C., Frazier Life Sciences X, L.P., FHMLS X, L.P., FHMLS X, L.L.C., Frazier Life Sciences Public Fund, L.P., FHMLSP, L.P., FHMLSP, L.L.C., Frazier Life Sciences Public Overage Fund, L.P., FHMLSP Overage, L.P., FHMLSP Overage, L.L.C., Frazier Life Sciences XI, L.P., FHMLS XI, L.P., FHMLS XI, L.L.C., Frazier Life Sciences XII, L.P., FHMLS XII, L.P., FHMLS XII, L.L.C., James N. Topper, Patrick J. Heron ×8 presentaciones | 20 de agosto de 2025 | 7,50% | Enmienda | Inversión pasiva | SEC |
| OrbiMed Advisors LLC, OrbiMed Capital GP VII LLC, OrbiMed Capital LLC ×7 presentaciones | 26 de agosto de 2022 | · | Presentación inicial | · | SEC |
| Bain Capital Life Sciences Fund, L.P., BCIP Life Sciences Associates, LP ×4 presentaciones | 8 de agosto de 2022 | · | Presentación inicial | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Informantes de la empresa 26 insiders · 12 directivos · 14 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| Todd Franklin Watanabe | Reporting Person's title: President and Chief Executive Officer | 3 de agosto de 2026 S | 717 203 | 0 | 10 | $-4 439 604 |
| Latha Vairavan | SVP Chief Financial Officer | 11 de mayo de 2026 S | 85 978 | 0 | 6 | $-148 496 |
| David Joseph Topper | Chief Financial Officer | 2 de abril de 2025 S | 182 774 | 0 | 0 | $0 |
| John W Smither | Chief Financial Officer | 13 de febrero de 2024 D | 11 365 | 0 | 0 | $0 |
| Scott L Burrows | Chief Financial Officer | 6 de marzo de 2023 S | 59 115 | 0 | 0 | $0 |
| Masaru Matsuda | Reporting Person's title: EVP, Chief Legal Officer | 16 de septiembre de 2026 S | 112 508 | 0 | 18 | $-2 207 960 |
| Patrick Burnett | Reporting Person's title: EVP, Chief Medical Officer | 19 de agosto de 2026 S | 117 592 | 0 | 18 | $-2 019 340 |
| Larry Todd Edwards | Reporting Person's title: EVP, Chief Commercial Officer | 27 de febrero de 2026 A | 175 178 | 0 | 6 | $-968 374 |
| Matthew Richard Moore | SVP and Chief Business Officer | 2 de mayo de 2024 S | 145 505 | 0 | 0 | $0 |
| Kenneth A. Lock | Chief Commercial Officer | 6 de marzo de 2023 S | 63 429 | 0 | 0 | $0 |
| Patricia A. Turney | SVP, Operations | 6 de marzo de 2023 S | 62 862 | 0 | 0 | $0 |
| David W Osborne | Chief Technical Officer | 6 de marzo de 2023 S | 268 854 | 0 | 0 | $0 |
| Howard G. Welgus | Consejero | 15 de septiembre de 2026 M | 35 841 | 0 | 12 | $-2 236 210 |
| Terrie Curran | Consejero | 27 de agosto de 2026 M | 23 526 | 0 | 3 | $-984 061 |
| Christopher Peetz | Consejero | 15 de julio de 2026 A | 4 315 | 0 | 0 | $0 |
| Sue-Jean Lin | Consejero | 15 de junio de 2026 S | 27 567 | 0 | 2 | $-898 455 |
| Neha Krishnamohan | Consejero | 5 de junio de 2026 A | 27 901 | 0 | 2 | $-939 510 |
| Amit Munshi | Consejero | 5 de junio de 2026 A | 9 799 | 0 | 0 | $0 |
| Halley E Gilbert | Consejero | 5 de junio de 2026 A | 27 901 | 0 | 1 | $-455 457 |
| Keith R Leonard | Consejero | 5 de junio de 2026 A | 27 901 | 0 | 1 | $-997 116 |
| Patrick J. Heron | Consejero | 5 de junio de 2026 A | 32 213 | 0 | 0 | $0 |
| Bhaskar Chaudhuri | Consejero | 12 de junio de 2025 A | 867 826 | 0 | 0 | $0 |
| Joseph L Turner | Consejero | 1 de junio de 2022 A | 4 312 | 0 | 0 | $0 |
| Jonathan Silverstein | Consejero | 2 de octubre de 2020 P | 902 286 | 0 | 0 | $0 |
| Daniel Estes | Consejero | 27 de febrero de 2020 A | · | 0 | 0 | $0 |
| Ricky Sun | · | 9 de junio de 2021 A | · | 0 | 0 | $0 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
Propiedad de ETFs Mantenido por 37 ETFs
El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.
| Fondo | Ponderación | Unidades | A fecha de | Fuente |
|---|---|---|---|---|
| RZG · Invesco Exchange-Traded Fund Trust | 1,63% | 77 200 SH | 2 de octubre de 2026 | Diario |
| PSCH · Invesco Exchange-Traded Fund Trust … | 1,58% | 108 697 SH | 2 de octubre de 2026 | Diario |
| BBP · ETFis Series Trust I | 1,52% | 55 666 NS | 31 de julio de 2026 | N-PORT |
| GURU · Global X Funds | 1,46% | 33 313 NS | 31 de julio de 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,54% | 98 745 NS | 31 de julio de 2026 | N-PORT |
| FYC · First Trust Exchange-Traded AlphaDE… | 0,41% | 197 027 NS | 31 de julio de 2026 | N-PORT |
| DWAS · Invesco Exchange-Traded Fund Trust … | 0,38% | 61 480 SH | 2 de octubre de 2026 | Diario |
| NUSC · Nushares ETF Trust | 0,22% | 107 502 NS | 31 de julio de 2026 | N-PORT |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,21% | 8 879 SH | 2 de octubre de 2026 | Diario |
| IBB · iShares Trust | 0,19% | 842 985 SH | 11 de septiembre de 2026 | Diario |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,18% | 122 691 SH | 19 de agosto de 2026 | Diario |
| IWO · iShares Trust | 0,18% | 1 074 467 SH | 11 de septiembre de 2026 | Diario |
| PWS · Pacer Funds Trust | 0,15% | 1 349 NS | 31 de julio de 2026 | N-PORT |
| FYX · First Trust Exchange-Traded AlphaDE… | 0,13% | 66 540 NS | 31 de julio de 2026 | N-PORT |
| BKSE · BNY Mellon ETF Trust | 0,12% | 3 883 NS | 31 de julio de 2026 | N-PORT |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,11% | 29 355 NS | 31 de julio de 2026 | N-PORT |
| RSSL · Global X Funds | 0,10% | 54 786 NS | 31 de julio de 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,09% | 658 480 SH | 19 de agosto de 2026 | Diario |
| IWM · iShares Trust | 0,09% | 2 915 298 SH | 11 de septiembre de 2026 | Diario |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,08% | 17 847 NS | 31 de julio de 2026 | N-PORT |
| ISCG · iShares Trust | 0,08% | 34 084 SH | 11 de septiembre de 2026 | Diario |
| ESML · iShares Trust | 0,07% | 88 662 SH | 11 de septiembre de 2026 | Diario |
| VFMO · VANGUARD WELLINGTON FUND | 0,07% | 55 080 SH | 19 de agosto de 2026 | Diario |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0,05% | 5 568 SH | 2 de octubre de 2026 | Diario |
| FHLC · FIDELITY COVINGTON TRUST | 0,04% | 53 372 NS | 31 de julio de 2026 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,04% | 45 122 SH | 2 de octubre de 2026 | Diario |
| VHT · VANGUARD WORLD FUND | 0,04% | 335 913 SH | 19 de agosto de 2026 | Diario |
| RWJ · Invesco Exchange-Traded Fund Trust … | 0,03% | 24 688 SH | 2 de octubre de 2026 | Diario |
| VXF · VANGUARD INDEX FUNDS | 0,03% | 1 307 970 SH | 19 de agosto de 2026 | Diario |
| WSML · iShares Trust | 0,02% | 6 362 SH | 11 de septiembre de 2026 | Diario |
| TILT · FlexShares Trust | 0,00% | 3 204 NS | 31 de julio de 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 152 928 SH | 11 de septiembre de 2026 | Diario |
| IWV · iShares Trust | 0,00% | 31 652 SH | 10 de septiembre de 2026 | Diario |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 3 565 928 SH | 19 de agosto de 2026 | Diario |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 9 521 SH | 19 de agosto de 2026 | Diario |
| PTH · Invesco Exchange-Traded Fund Trust | 0,00% | 2 SH | 2 de octubre de 2026 | Diario |
| ISCB · iShares Trust | · | 4 781 SH | 11 de septiembre de 2026 | Diario |
ARQT Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
calificación · 14 analistas
COMPRA
Objetivo mediano
$38.00
+51,0%
4 28,6%
Compra fuerte
8 57,1%
Compra
2 14,3%
Mantener
0 0,0%
Venta
0 0,0%
Venta fuerte
Precio objetivo a 12 meses
7 analistas · 2026-10-01Objetivo medio $37.00 +47,1%
← Por Debajo de Todos los Objetivos
Precio Actual $25.16
Mín$34.00
Media$37.00
Máx$40.00
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
Base del ejercicio fiscal, precios al cierre del último ejercicio fiscal de cada empresa.
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| ARQT | $3.58B | -223.4 | 91.3% | -4.3% | -9.8% | · |
| CDNA | $959M | -47.1 | 13.8% | -5.6% | -6.8% | · |
| ACAD | $4.55B | 11.6 | 11.9% | 36.5% | 38.1% | · |
| DNLI | $2.58B | -5.6 | 204.7% | · | -50.2% | · |
| RCUS | $2.99B | -7.2 | -4.3% | -142.9% | -59.8% | · |
| PGEN | $1.48B | -3.1 | 146.7% | -2588.2% | 3159.1% | · |
| PURR | $1.58B | 2.5 | · | 3229.8% | 24.8% | · |
| DYN | $3.23B | -5.6 | · | · | -57.8% | · |
| BEAM | $2.82B | -34.2 | 120.0% | -57.2% | -7.0% | · |
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
Seleccione las métricas que le importan: haga clic en el + junto a cualquier fila en Fundamentales completos arriba.
Tu selección se guarda y te sigue en todos los tickers.
Fuente: SEC 10-Q presentada el Ago 5, 2026